ebomi
Colour theme
Sign in
Insider · CIK 0001465914

Davis Aaron I.

CIK 0001465914 Name as filed on the most recent filing

Filed as Davis Aaron I. (39)

105 transaction lines · from 39 filings · filed 2017-01-10 to 2024-11-07 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

45 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2022-01-04 S, Open-market sale iTeos Therapeutics, Inc.ITOS 1,239,486, disposed Open Form 4 filing 0000899243-22-001072
2022-01-04 S, Open-market sale iTeos Therapeutics, Inc.ITOS 497,701, disposed Open Form 4 filing 0000899243-22-001072
2022-01-04 S, Open-market sale iTeos Therapeutics, Inc.ITOS 406,110, disposed Open Form 4 filing 0000899243-22-001072
2022-01-04 S, Open-market sale iTeos Therapeutics, Inc.ITOS 340,310, disposed Open Form 4 filing 0000899243-22-001072
2022-01-04 S, Open-market sale iTeos Therapeutics, Inc.ITOS 136,062, disposed Open Form 4 filing 0000899243-22-001072
2022-01-04 S, Open-market sale iTeos Therapeutics, Inc.ITOS 114,467, disposed Open Form 4 filing 0000899243-22-001072
2022-01-03 S, Open-market sale iTeos Therapeutics, Inc.ITOS 6 lines 24,677,379, disposed Open Form 4 filing 0000899243-22-001072
2021-11-19 S, Open-market sale Odonate Therapeutics, Inc.ODT 2 lines 333,780, disposed Open Form 4 filing 0000899243-21-045438
2021-11-18 S, Open-market sale Odonate Therapeutics, Inc.ODT 487,250, disposed Open Form 4 filing 0000899243-21-045438
2021-11-17 S, Open-market sale Odonate Therapeutics, Inc.ODT 2 lines 1,678,918, disposed Open Form 4 filing 0000899243-21-045438
2021-09-17 P, Open-market purchase Tyra Biosciences, Inc.TYRA 10,000,000, acquired Open Form 4 filing 0000899243-21-036419
2021-04-27 P, Open-market purchase Rain Therapeutics Inc.RAIN 17,425,000, acquired Open Form 4 filing 0000899243-21-017115
2021-04-23 P, Open-market purchase Rain Therapeutics Inc.RAIN 2 lines 2,423,250, acquired Open Form 4 filing 0000899243-21-017115
2021-03-05 S, Open-market sale Mirati Therapeutics, Inc.MRTX 4 lines 72,460,905, disposed Open Form 4 filing 0000899243-21-010812
2020-12-30 P, Open-market purchase Odonate Therapeutics, Inc.ODT 1,746,380, acquired Open Form 4 filing 0000899243-20-035534
2020-12-29 P, Open-market purchase Odonate Therapeutics, Inc.ODT 3,849,548, acquired Open Form 4 filing 0000899243-20-035534
2020-12-28 P, Open-market purchase Odonate Therapeutics, Inc.ODT 1,267,500, acquired Open Form 4 filing 0000899243-20-035534
2020-10-30 S, Open-market sale Mirati Therapeutics, Inc.MRTX 2 lines 80,800,000, disposed Open Form 4 filing 0000899243-20-030060
2020-09-29 P, Open-market purchase Odonate Therapeutics, Inc.ODT 1,717,760, acquired Open Form 4 filing 0000899243-20-026513
2020-09-28 P, Open-market purchase Odonate Therapeutics, Inc.ODT 1,214,396, acquired Open Form 4 filing 0000899243-20-026513
2020-09-25 P, Open-market purchase PMV Pharmaceuticals, Inc.PMVP 17,100,000, acquired Open Form 4 filing 0001209191-20-052341
2020-09-09 P, Open-market purchase Odonate Therapeutics, Inc.ODT 1,232,720, acquired Open Form 4 filing 0000899243-20-024781
2020-09-08 P, Open-market purchase Odonate Therapeutics, Inc.ODT 276,172, acquired Open Form 4 filing 0000899243-20-024781
2020-09-04 P, Open-market purchase Odonate Therapeutics, Inc.ODT 1,862,739, acquired Open Form 4 filing 0000899243-20-024781
2020-08-28 P, Open-market purchase Odonate Therapeutics, Inc.ODT 20,000,003, acquired Open Form 4 filing 0000899243-20-023767
2020-07-28 P, Open-market purchase iTeos Therapeutics, Inc.ITOS 2 lines 27,075,000, acquired Open Form 4 filing 0000899243-20-020730
2020-07-21 P, Open-market purchase Pandion Therapeutics, Inc.PAND 12,999,996, acquired Open Form 4 filing 0000899243-20-019894
2019-01-08 S, Open-market sale Mirati Therapeutics, Inc.MRTX 2 lines 528,000, disposed Open Form 4 filing 0000899243-19-000910
2019-01-07 S, Open-market sale Mirati Therapeutics, Inc.MRTX 3 lines 1,855,803, disposed Open Form 4 filing 0000899243-19-000910
2018-12-26 P, Open-market purchase Odonate Therapeutics, Inc.ODT 311,815, acquired Open Form 4 filing 0000899243-18-031846
2018-12-21 P, Open-market purchase Odonate Therapeutics, Inc.ODT 2 lines 1,347,015, acquired Open Form 4 filing 0000899243-18-031846
2018-10-24 P, Open-market purchase Odonate Therapeutics, Inc.ODT 394,753, acquired Open Form 4 filing 0000899243-18-027534
2018-03-26 P, Open-market purchase Odonate Therapeutics, Inc.ODT 754,097, acquired Open Form 4 filing 0000899243-18-008513

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 24
  • Open-market sale 21
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Davis Aaron I., insider transactions. Retrieved 2026-08-26 from https://ebomi.com/insider/0001465914

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.